{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:43:11Z","timestamp":1791225791112,"version":"4.1.0"},"reference-count":231,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Sci. OA"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.2144\/fsoa-2022-0011","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T12:27:43Z","timestamp":1675427263000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Co-Infection Associated with SARS-CoV-2 and Their Management"],"prefix":"10.1080","volume":"8","author":[{"given":"Vivek P","family":"Chavda","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics &amp; Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, Gujarat, 380009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayushi B","family":"Patel","sequence":"additional","affiliation":[{"name":"Pharmacy Section, LM College of Pharmacy, Ahmedabad, Gujarat, 380058, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Pandya","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences &amp; Technology, Institute of Chemical Technology, Mumbai, 400 019, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitkumar K","family":"Vora","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Patravale","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences &amp; Technology, Institute of Chemical Technology, Mumbai, 400 019, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara M","family":"Tambuwala","sequence":"additional","affiliation":[{"name":"College of Science, University of Lincoln, Brayford Campus, Lincoln, LN6 7TS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-6338","authenticated-orcid":false,"given":"Alaa AA","family":"Aljabali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics &amp; Pharmaceutical Technology, Yarmouk University, Faculty of Pharmacy, Irbid, 566, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9953-3848","authenticated-orcid":false,"given":"\u00c1ngel","family":"Serrano-Aroca","sequence":"additional","affiliation":[{"name":"Biomaterials &amp; Bioengineering Lab, Centro de Investigaci\u00f3n Traslacional San Alberto Magno, Universidad Cat\u00f3lica de Valencia San Vicente M\u00e1rtir, c\/Guillem de Castro 94, Valencia, 46001, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-2464","authenticated-orcid":false,"given":"Vijay","family":"Mishra","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8499-9891","authenticated-orcid":false,"given":"Murtaza M","family":"Tambuwala","sequence":"additional","affiliation":[{"name":"Lincoln Medical School University of Lincoln, Brayford Campus, Lincoln, LN6 7TS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-138577"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25245906"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.138436"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"MachhiJ HerskovitzJ SenanAMet al.The natural history pathobiology and clinical manifestations of SARS-CoV-2 infections. (2020).","DOI":"10.1007\/s11481-020-09944-5"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Bar-onYM FlamholzAVI PhillipsROBet al.SARS-CoV-2 (COVID-19) by the numbers. 2 1\u201315 (2020).","DOI":"10.7554\/eLife.57309.sa2"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"XieSHUYUN OuJIANMING. Infectivity of severe acute respiratory syndrome during. 510 502\u2013510 (2009).","DOI":"10.1016\/S0895-3988(10)60008-6"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"WeiWE LiZ ChiewCJet al.Presymptomatic transmission of SARS-CoV-2 \u2013 Singapore . 69 411\u2013415 (2020).","DOI":"10.15585\/mmwr.mm6914e1"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00317"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00483-y"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02911-9"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.07.021"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccmp.2021.100004"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1987223"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060631"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z"},{"key":"e_1_3_3_20_1","unstructured":"Wikipedia. Variants of SARS-CoV-2. 2021."},{"key":"e_1_3_3_21_1","first-page":"614","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","author":"Harvey WT","year":"2021","unstructured":"HarveyWT , CarabelliAM , JacksonBet al.SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol., 614 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"e_1_3_3_22_1","unstructured":"ReesH RoperoAM ScBet al.Special report SARS-CoV-2 variants and vaccines. 1\u20138 (2021)."},{"key":"e_1_3_3_23_1","unstructured":"CDC. SARS-CoV-2 variant classifications and definitions (2021). www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant-info.html"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002662R"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00628-0"},{"key":"e_1_3_3_26_1","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","volume":"52","author":"Khatri A","year":"2020","unstructured":"KhatriA , ChangK , BerlinrutIet al.Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information52 (2020).","journal-title":"The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27717"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.899633"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2021.100013"},{"key":"e_1_3_3_30_1","first-page":"101606","article-title":"The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines","volume":"25","author":"Mohammadi M","year":"2021","unstructured":"MohammadiM , ShayestehpourM , MirzaeiH. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines. Brazilian J Infect Dis an Off Publ Brazilian Soc Infect Dis.25, 101606 (2021).","journal-title":"Brazilian J Infect Dis an Off Publ Brazilian Soc Infect Dis."},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2313"},{"key":"e_1_3_3_32_1","article-title":"About variants of the virus that causes COVID-19","author":"CDC","year":"2021","unstructured":"CDC. About variants of the virus that causes COVID-19. CDC Gov. (2021).","journal-title":"CDC Gov."},{"key":"e_1_3_3_33_1","unstructured":"WHO. The effects of virus variants on COVID-19 vaccines. 1\u20135 (2021). www.whoint"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.112816"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccmp.2022.100021"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2022-0064"},{"key":"e_1_3_3_37_1","unstructured":"VivekP. Chavda. Omicron variant (B.1.1.529) of SARS-CoV-2: threat for the elderly? (2020)."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106656"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106670"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24285-4"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2022-0135"},{"key":"e_1_3_3_42_1","first-page":"355","article-title":"mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants","volume":"55","author":"Wu K","year":"2021","unstructured":"WuK , WernerAP , MolivaJIet al.mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. BioRxiv Prepr. Serv. Biol.55, 355\u2013365 (2021).","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30651-4"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n196"},{"key":"e_1_3_3_45_1","article-title":"COVID-19 vaccine tracker","author":"Jeff Craven","year":"2021","unstructured":"JeffCraven. COVID-19 vaccine tracker. Regul. Focus. (2021). www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker","journal-title":"Regul. Focus."},{"key":"e_1_3_3_46_1","unstructured":"WHO. Vaccine information."},{"key":"e_1_3_3_47_1","first-page":"524","article-title":"Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19)","volume":"54","author":"Aleem A","year":"2022","unstructured":"AleemA , AkbarSamad AB , SlenkerAK. Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). Treasure Island (FL)54524\u2013540 (2022).","journal-title":"Treasure Island (FL)"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030367"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.885482"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1987223"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116185"},{"key":"e_1_3_3_52_1","doi-asserted-by":"crossref","unstructured":"Lopes-PachecoM SilvaPL CruzFF. Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. 12 1\u201323 (2021).","DOI":"10.3389\/fphys.2021.593223"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0120OC"},{"key":"e_1_3_3_54_1","unstructured":"SteutenK KimH WidenJCet al.Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors. 2020 1\u201332"},{"key":"e_1_3_3_55_1","unstructured":"SummaryE. Therapeutic Management of Patients With COVID-19. 2021 75\u201388"},{"key":"e_1_3_3_56_1","unstructured":"NovemberO AuthorizationEU DecemberOet al.The COVID-19 Treatment Guidelines panel's statement on baricitinib for the treatment of adults with COVID-19. 2021 6\u20137"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100086"},{"key":"e_1_3_3_58_1","unstructured":"CovidT PanelTG CovidAW. What's new in the guidelines. 2019 4\u20135 (2021)."},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021\u20130168"},{"key":"e_1_3_3_60_1","first-page":"1","article-title":"Fact sheet for healthcare providers Emergency Use Authorization (EUA) for baricitinib","author":"Eli Lilly and Company","year":"2021","unstructured":"Eli Lilly and Company. Fact sheet for healthcare providers Emergency Use Authorization (EUA) for baricitinib. US Food Drug Adm.1\u201329 (2021).","journal-title":"US Food Drug Adm."},{"key":"e_1_3_3_61_1","unstructured":"ControlD. What clinicians need to know about the new oral antiviral medications for COVID-19. (2022)."},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-021-00240-8"},{"key":"e_1_3_3_63_1","first-page":"1","article-title":"Therapeutic monoclonal antibodies for COVID-19 management: an update","author":"Chavda VP","year":"2022","unstructured":"ChavdaVP , PrajapatiR , LathigaraDet al.Therapeutic monoclonal antibodies for COVID-19 management: an update. Expert Opin Biol Ther.1\u201318 (2022).","journal-title":"Expert Opin Biol Ther."},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-020-09915-3"},{"key":"e_1_3_3_65_1","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","volume":"52","author":"Dong M","year":"2020","unstructured":"DongM , ZhangJ , MaXet al.Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information52 (2020).","journal-title":"The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information"},{"key":"e_1_3_3_66_1","unstructured":"MundellBE PreidtR. Many show long-term organ damage after COVID. (2021)"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019"},{"key":"e_1_3_3_68_1","article-title":"Black Fungus: these 2 states account for nearly 42% of India's 28,252 mucormycosis cases","volume":"8","author":"Meghna Sen","year":"2021","unstructured":"MeghnaSen. Black Fungus: these 2 states account for nearly 42% of India's 28,252 mucormycosis cases. Livemint.8 (2021).","journal-title":"Livemint."},{"key":"e_1_3_3_69_1","doi-asserted-by":"crossref","unstructured":"ThackerD. Multisystem Inflammatory Syndrome in Children (MIS-C): Delaware J Public Heal. 6 36\u201339 (2020).","DOI":"10.32481\/djph.2020.07.010"},{"key":"e_1_3_3_70_1","first-page":"19","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","author":"Or Caspi","year":"2020","unstructured":"OrCaspi , MichaelJ , SmartRBN. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. Ann. Oncol., 19\u201321 (2020).","journal-title":"Ann. Oncol."},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-1503-4"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00528-2"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14619"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2521LE"},{"key":"e_1_3_3_75_1","article-title":"Global prevalence of COVID-19-associated mucormycosis (CAM): living Systematic Review and Meta-Analysis","volume":"7","author":"Hussain S","year":"2021","unstructured":"HussainS , RiadA , SinghAet al.Global prevalence of COVID-19-associated mucormycosis (CAM): living Systematic Review and Meta-Analysis. J. Fungi (Basel, Switzerland)7 (2021).","journal-title":"J. Fungi (Basel, Switzerland)"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01104-y"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2020.0872"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6175964"},{"key":"e_1_3_3_79_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00228-20","article-title":"Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\/COVID-19 detection","volume":"34","author":"Safiabadi Tali SH","year":"2021","unstructured":"SafiabadiTali SH , LeBlancJJ , SadiqZet al.Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\/COVID-19 detection. Clin. Microbiol. Rev.34, 1\u201363 (2021).","journal-title":"Clin. Microbiol. Rev."},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25709"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.735922"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103812"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-021-00484-3"},{"key":"e_1_3_3_84_1","volume-title":"StatPearls.","author":"Basu-Ray I","year":"2021","unstructured":"Basu-RayI , AlmaddahNk , AdeboyeAet al.Cardiac manifestations of coronavirus (COVID-19) [updated 2021 May 19]. In: StatPearls.StatPearls Publishing, FL, USA (2021). www.ncbi.nlm.nih.gov\/books\/NBK556152\/"},{"key":"e_1_3_3_85_1","volume-title":"Angiogenesis.","author":"Smadja DM","year":"2021","unstructured":"SmadjaDM , MentzerSJ , FontenayMet al.COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis.Springer, The Netherlands (2021)."},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.07.023"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00640-2"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01689-3"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110678"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2020.7332"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-00123-0"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00664"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.930340"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30203-0"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.630986"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.705908"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1159\/000512683"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00452-0"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2176"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00426-4"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00458"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030446"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43066-021-00082-y"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-00357-4"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020386"},{"key":"e_1_3_3_106_1","first-page":"1","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","author":"Sharma S","year":"2021","unstructured":"SharmaS , GroverM , BhargavaSet al.Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J. Laryngol. Otol.1\u20136 (2021).","journal-title":"J. Laryngol. Otol."},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118431"},{"key":"e_1_3_3_108_1","unstructured":"KallapurAS YenEY SinghRR. Vascular thrombosis in COVID-19: a potential association with antiphospholipid antibodies: a rapid Systematic Review of pathology and laboratory medicine UCLA Los Angeles CA. of Medicine University of California at Los Angeles (UCLA) David Geff. 1670 (2020)."},{"key":"e_1_3_3_109_1","first-page":"13","article-title":"Long-covid and post-covid health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms","volume":"2021","author":"Andrade BS","year":"2021","unstructured":"AndradeBS , SiqueiraS , deAssis Soares WRet al.Long-covid and post-covid health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses2021, 13 (2021).","journal-title":"Viruses"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04544-w"},{"key":"e_1_3_3_111_1","first-page":"1","article-title":"Gastrointestinal disorders in COVID-19 patients: a great imitator","author":"Syam AF","year":"2021","unstructured":"SyamAF. Gastrointestinal disorders in COVID-19 patients: a great imitator. Med. J. Indones, 1\u20134 (2021).","journal-title":"Med. J. Indones"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00416-6"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9062011"},{"key":"e_1_3_3_114_1","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","volume":"52","author":"Chih-Cheng Lai a","year":"2020","unstructured":"Chih-ChengLai a , Tzu-PingShih b , Wen-ChienKo c , Hung-JenTang d P-RH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information52 (2020).","journal-title":"The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.06.011"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050436"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72718-9"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00362-20"},{"key":"e_1_3_3_119_1","first-page":"14","article-title":"Nasal medication conveyance framework: an approach for brain delivery from essential to cutting edge","volume":"6","author":"Dhaval Shah","year":"2016","unstructured":"DhavalShah , Vivek ChavdaHT. Nasal medication conveyance framework: an approach for brain delivery from essential to cutting edge. Res. Rev. J. Med.6, 14\u201327 (2016).","journal-title":"Res. Rev. J. Med."},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-63761-3_26"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30017"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102967"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026"},{"key":"e_1_3_3_124_1","first-page":"1","article-title":"Title of the article: paranasal mucormycosis in COVID-19 patient","author":"Saldanha M","year":"2021","unstructured":"SaldanhaM , ReddyR , VincentMJ. Title of the article: paranasal mucormycosis in COVID-19 patient. Indian J. Otolaryngol. Head Neck Surg., 1\u20134 (2021).","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05460-2"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241663"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2021.07.009"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13256"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir865"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3637"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030523"},{"key":"e_1_3_3_132_1","first-page":"265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada A","year":"2020","unstructured":"SkiadaA , PavleasI , Drogari-ApiranthitouM. Epidemiology and diagnosis of mucormycosis: an update. J. Fungi (Basel, Switzerland)6, 265 (2020). https:\/\/pubmed.ncbi.nlm.nih.gov\/33147877","journal-title":"J. Fungi (Basel, Switzerland)"},{"key":"e_1_3_3_133_1","first-page":"e13163","article-title":"A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19","volume":"13","author":"Waizel-Haiat S","year":"2021","unstructured":"Waizel-HaiatS , Guerrero-PazJA , Sanchez-HurtadoLet al.A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19. Cureus13, e13163\u2013e13163 (2021).","journal-title":"Cureus"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15081.1"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3774_20"},{"key":"e_1_3_3_136_1","first-page":"1","article-title":"A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis","author":"Pasero D","year":"2020","unstructured":"PaseroD , SannaS , LiperiCet al.A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection, 1\u20136 (2020).","journal-title":"Infection"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2021.101125"},{"key":"e_1_3_3_138_1","first-page":"59","article-title":"Mucormycosis of the central nervous system","volume":"5","author":"Chikley A","year":"2019","unstructured":"ChikleyA , Ben-AmiR , KontoyiannisDP. Mucormycosis of the central nervous system. J. Fungi (Basel, Switzerland)5, 59 (2019).","journal-title":"J. Fungi (Basel, Switzerland)"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.179192"},{"key":"e_1_3_3_140_1","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","author":"Mehta S","year":"2020","unstructured":"MehtaS , PandeyA. Rhino-orbital mucormycosis associated with COVID-19. Cureuse10726 (2020).","journal-title":"Cureus"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.3390\/biologics1030020"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_297_21"},{"key":"e_1_3_3_143_1","first-page":"298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"JohnTM , JacobCN , KontoyiannisDP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J. Fungi (Basel, Switzerland)7, 298 (2021).","journal-title":"J. Fungi (Basel, Switzerland)"},{"key":"e_1_3_3_144_1","unstructured":"GhaziabadI. COVID: india's \u2018white fungus\u2019 infections raise new health concerns COVID-19 Special: \u2018Black fungus\u2019 infections rise in India COVID: An unfolding health crisis in rural India. 1\u20133 (2021)."},{"key":"e_1_3_3_145_1","first-page":"1","article-title":"White Fungus","volume":"30","author":"Sterling B","year":"2020","unstructured":"SterlingB. White Fungus. Beyond30, 1\u20132 (2020)","journal-title":"Beyond"},{"key":"e_1_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.3109\/07388550903427272"},{"key":"e_1_3_3_147_1","unstructured":"NowS. Black fungus white fungus and yellow fungus: busting some common myths related to the dangerous fungal infections developed post-COVID recovery. 1\u20135 (2021)."},{"key":"e_1_3_3_148_1","unstructured":"LoadedTHEF. Explained: What Are Black White. 1\u201310 (2021)."},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-022-02824-6"},{"key":"e_1_3_3_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106619"},{"key":"e_1_3_3_151_1","first-page":"1","article-title":"COVID-19: how do we explain \u201chappy\u201d hypoxia?","author":"Huzar T","year":"2020","unstructured":"HuzarT. COVID-19: how do we explain \u201chappy\u201d hypoxia?Med. News Today1\u20136 (2020).","journal-title":"Med. News Today"},{"key":"e_1_3_3_152_1","unstructured":"WhatS IsE HypoxiaH. Happy hypoxia: decoding the mystery COVID-19 patients. 4\u20137 (2021)."},{"key":"e_1_3_3_153_1","first-page":"1","article-title":"Silent hypoxia or happy hypoxia in COVID-19 patients what is silent or happy hypoxia? What are the symptoms of silent or happy hypoxia to watch for? What causes silent or happy hypoxia in COVID-19 patients?","author":"A-z H","year":"2021","unstructured":"A-zH. Silent hypoxia or happy hypoxia in COVID-19 patients what is silent or happy hypoxia? What are the symptoms of silent or happy hypoxia to watch for? What causes silent or happy hypoxia in COVID-19 patients?. How to Identify Silent or Happy Hypoxia in Pa.1\u20133 (2021).","journal-title":"How to Identify Silent or Happy Hypoxia in Pa."},{"key":"e_1_3_3_154_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01614-1"},{"key":"e_1_3_3_155_1","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","volume":"52","author":"Brouqui P","year":"2020","unstructured":"BrouquiP , AmraneS , MillionMet al.Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information52 (2020).","journal-title":"The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information"},{"key":"e_1_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.573044"},{"key":"e_1_3_3_157_1","unstructured":"DchSG ChopraN SinghAet al.Unusual clinical manifestations and outcome of multisystem inflammatory syndrome in children (MIS-C) in a tertiary care hospital of North India. 1\u20139 (2021)."},{"key":"e_1_3_3_158_1","doi-asserted-by":"crossref","unstructured":"McmurrayJC MayJW CunninghamMW. Multisystem inflammatory syndrome in children (MIS-C) a post-viral myocarditis and systemic vasculitis \u2013 a critical review of its pathogenesis and treatment. 8 11\u201323 (2020).","DOI":"10.3389\/fped.2020.626182"},{"key":"e_1_3_3_159_1","doi-asserted-by":"crossref","unstructured":"RostadBS ShahJH RostadCAet al.Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19. (2021).","DOI":"10.1007\/s00247-020-04921-9"},{"key":"e_1_3_3_160_1","unstructured":"PatelM MouskasK SimonsNet al.Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). (2020)."},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.003"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2021-0463"},{"key":"e_1_3_3_163_1","doi-asserted-by":"crossref","unstructured":"VellaLA ImmunolS VellaLAet al.Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. 7570 1\u201318 (2021).","DOI":"10.1126\/sciimmunol.abf7570"},{"key":"e_1_3_3_164_1","unstructured":"ConsiglioCR NicolaC SardhF PouCet al.The immunology of multisystem inflammatory syndrome in children with COVID-19. 183 4968\u2013981 (2020)."},{"key":"e_1_3_3_165_1","first-page":"13","article-title":"COVID-19, antiphospholipid antibodies, and catastrophic antiphospholipid syndrome: a possible association?","author":"El Hasbani G","year":"2020","unstructured":"ElHasbani G , TaherAT , JawadAet al.COVID-19, antiphospholipid antibodies, and catastrophic antiphospholipid syndrome: a possible association?Clin. Med. Insights Arthritis Musculoskelet Disord.13 (2020).","journal-title":"Clin. Med. Insights Arthritis Musculoskelet Disord."},{"key":"e_1_3_3_166_1","unstructured":"BustamanteJG GoyalA ; SinghalM. StatPearls \u2013 NCBI Bookshelf Antiphospholipid syndrome. 1200\u20131500 (2022)."},{"key":"e_1_3_3_167_1","doi-asserted-by":"crossref","unstructured":"CavalliE BramantiA CiurleoRet al.Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: diagnostic and therapeutic perspectives (Review). 903\u2013912 (2020).","DOI":"10.3892\/ijmm.2020.4659"},{"key":"e_1_3_3_168_1","first-page":"557","article-title":"[Antiphospholipid antibodies: clinical significance and biological diagnosis]","volume":"58","author":"Arnoux D","year":"2000","unstructured":"ArnouxD , Bouti\u00e8reB , SanmarcoM. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Ann Biol Clin (Paris)58, 557\u2013574 (2000).","journal-title":"Ann Biol Clin (Paris)"},{"key":"e_1_3_3_169_1","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4154"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2044800"},{"key":"e_1_3_3_171_1","article-title":"Antiphospholipid syndrome and COVID-19 \u2013 what you should know","author":"Serrano M","unstructured":"SerranoM , EspinosaG , SerranoA , CerverabR. Antiphospholipid syndrome and COVID-19 \u2013 what you should know. Elsevier Public Health Emergency Collection","journal-title":"Elsevier Public Health Emergency Collection"},{"key":"e_1_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.1530\/REP-15-0545"},{"key":"e_1_3_3_173_1","doi-asserted-by":"publisher","DOI":"10.26502\/acbr.50170123"},{"key":"e_1_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.06.025"},{"key":"e_1_3_3_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102909"},{"key":"e_1_3_3_176_1","doi-asserted-by":"crossref","unstructured":"IndexCC. Presence of antiphospholipid antibodies in COVID-19: a case series study. 80 19\u201320 (2021).","DOI":"10.1016\/j.autrev.2021.102910"},{"key":"e_1_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102941"},{"key":"e_1_3_3_178_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2013656"},{"key":"e_1_3_3_179_1","doi-asserted-by":"publisher","DOI":"10.1177\/1179544120978667"},{"key":"e_1_3_3_180_1","doi-asserted-by":"crossref","unstructured":"KawasakiT KawaiT. Toll-like receptor signaling pathways. 5 1\u20138 (2014).","DOI":"10.3389\/fimmu.2014.00461"},{"key":"e_1_3_3_181_1","doi-asserted-by":"crossref","unstructured":"ZhangS LiuY WangXet al.SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. 7 1\u201322 (2020).","DOI":"10.1186\/s13045-020-00954-7"},{"key":"e_1_3_3_182_1","first-page":"1","article-title":"Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots","volume":"5","author":"Tung ML","year":"2021","unstructured":"TungML , TanB , CherianRet al.Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol. Adv. Pract.5, 1\u201314 (2021).","journal-title":"Rheumatol. Adv. Pract."},{"key":"e_1_3_3_183_1","doi-asserted-by":"crossref","unstructured":"TangK HsuB ChenDet al.Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review. 12 (2021).","DOI":"10.3389\/fimmu.2021.645013"},{"key":"e_1_3_3_184_1","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4154"},{"key":"e_1_3_3_185_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00594-2020"},{"key":"e_1_3_3_186_1","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.169"},{"key":"e_1_3_3_187_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08797-3"},{"key":"e_1_3_3_188_1","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2020.0101"},{"key":"e_1_3_3_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2021.04.001"},{"key":"e_1_3_3_190_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.550571"},{"key":"e_1_3_3_191_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.013276"},{"key":"e_1_3_3_192_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.20.0278"},{"key":"e_1_3_3_193_1","first-page":"14","article-title":"Asthma and COVID-19: what do we know now","author":"Hughes-Visentin A","year":"2020","unstructured":"Hughes-VisentinA , PaulABM. Asthma and COVID-19: what do we know now. Clin. Med. Insights Circ Respir. Pulm. Med.14 (2020).","journal-title":"Clin. Med. Insights Circ Respir. Pulm. Med."},{"key":"e_1_3_3_194_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314515"},{"key":"e_1_3_3_195_1","doi-asserted-by":"publisher","DOI":"10.5152\/TurkThoracJ.2020.20091"},{"key":"e_1_3_3_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106261"},{"key":"e_1_3_3_197_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113316"},{"key":"e_1_3_3_198_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-00122-3"},{"key":"e_1_3_3_199_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.606755"},{"key":"e_1_3_3_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.09.018"},{"key":"e_1_3_3_201_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26217"},{"key":"e_1_3_3_202_1","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","volume":"52","author":"Mohanty A","year":"2020","unstructured":"MohantyA , AgnihotriS , MehtaAet al.Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information.52 (2020).","journal-title":"The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information."},{"key":"e_1_3_3_203_1","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","volume":"52","author":"Florian Slimanoa","year":"2020","unstructured":"FlorianSlimanoa , b* , AmandineBaudouincet al.Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information52 (2020).","journal-title":"The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information"},{"key":"e_1_3_3_204_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202741"},{"key":"e_1_3_3_205_1","doi-asserted-by":"crossref","unstructured":"ElgoharyS ElkhodiryAA AminNSet al.Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? (2021).","DOI":"10.3390\/cells10020302"},{"key":"e_1_3_3_206_1","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19","volume":"52","author":"Zhang L","year":"2020","unstructured":"ZhangL , ZhuF , XieLet al.Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information52 (2020).","journal-title":"The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company's Public News and Information"},{"key":"e_1_3_3_207_1","first-page":"1","article-title":"A narrative review of the pathophysiology of COVID-19 infection among cancer patients: current evidence and research perspectives","volume":"4","author":"Ramani VK","year":"2021","unstructured":"RamaniVK , NaikR. A narrative review of the pathophysiology of COVID-19 infection among cancer patients: current evidence and research perspectives. Heal Sci Reports4, 1\u201310 (2021).","journal-title":"Heal Sci Reports"},{"key":"e_1_3_3_208_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0067"},{"key":"e_1_3_3_209_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14040759"},{"key":"e_1_3_3_210_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.850862"},{"key":"e_1_3_3_211_1","first-page":"153537022210929","article-title":"Convalescent serum-derived exosomes: attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery","author":"Krishnan A","year":"2022","unstructured":"KrishnanA , GangadaranP , ChavdaVPet al.Convalescent serum-derived exosomes: attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery. Exp. Biol. Med. (Maywood), 15353702221092984 (2022).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"e_1_3_3_212_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.867655"},{"key":"e_1_3_3_213_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006520"},{"key":"e_1_3_3_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2020.06.035"},{"key":"e_1_3_3_215_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0474-5"},{"key":"e_1_3_3_216_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007335"},{"key":"e_1_3_3_217_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-00737-1"},{"key":"e_1_3_3_218_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3320"},{"key":"e_1_3_3_219_1","first-page":"1","article-title":"COVID-19 and male reproductive system: pathogenic features and possible mechanisms","author":"Ardestani Zadeh A","year":"2021","unstructured":"ArdestaniZadeh A , ArabD. COVID-19 and male reproductive system: pathogenic features and possible mechanisms. J. Mol. Histol., 1\u201310 (2021).","journal-title":"J. Mol. Histol."},{"key":"e_1_3_3_220_1","unstructured":"MartiniAE. COVID-19 in pregnancy. 2 2200 (2020)."},{"key":"e_1_3_3_221_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3391"},{"key":"e_1_3_3_222_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.12131"},{"key":"e_1_3_3_223_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00895-4"},{"key":"e_1_3_3_224_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0398-3"},{"key":"e_1_3_3_225_1","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2020.0050"},{"key":"e_1_3_3_226_1","first-page":"145","article-title":"The neurological manifestations of COVID-19","volume":"11","author":"de Seze J","year":"2020","unstructured":"de SezeJ. The neurological manifestations of COVID-19. Prat. Neurol. \u2013 FMC11, 145\u2013146 (2020).","journal-title":"Prat. Neurol. \u2013 FMC"},{"key":"e_1_3_3_227_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420932036"},{"key":"e_1_3_3_228_1","first-page":"10","article-title":"Psychiatric face of COVID-19","author":"Steardo L","year":"2020","unstructured":"SteardoL , SteardoL , VerkhratskyA. Psychiatric face of COVID-19. Transl. Psychiatry10 (2020).","journal-title":"Transl. Psychiatry"},{"key":"e_1_3_3_229_1","unstructured":"ConversationFT. India is struggling against a rapid increase in Covid-19 cases but a nasty and rare fungal infection affecting some coronavirus patients is dealing the country a double blow. 1\u20139 (2021)."},{"key":"e_1_3_3_230_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006697"},{"key":"e_1_3_3_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32656-8"},{"key":"e_1_3_3_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2021.02.001"},{"key":"e_1_3_3_233_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-020-00230-w"}],"container-title":["Future Science OA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2144\/fsoa-2022-0011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:45Z","timestamp":1719125205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2144\/fsoa-2022-0011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":231,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.2144\/fsoa-2022-0011"],"URL":"https:\/\/doi.org\/10.2144\/fsoa-2022-0011","relation":{},"ISSN":["2056-5623"],"issn-type":[{"value":"2056-5623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"FSO819"}}